The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest. Source: New York Times
Posts published in “Antibodies”
A Better Way to Measure Immunity in Children
Some scientists believe that a clearer picture of Covid vaccine efficacy could have emerged sooner if investigators had tracked certain immune cells, not just antibodies. Source: New York Times
Who Is Protected Against Monkeypox?
Older people who received smallpox vaccinations may yet have some immunity, researchers say. Healthy children and adults generally do not become severely ill. Source: New York Times
The Coronavirus Has Infected More Than Half of Americans, the C.D.C. Reports
But prior infection does not guarantee protection from the virus, officials said, and Americans should still get vaccinated and boosted. Source: New York Times
Hospitals Scramble as Antibody Treatments Fail Against Omicron
The single remaining monoclonal antibody therapy effective against the variant is now in short supply in the U.S., imperiling an option that doctors and hospitals have relied on. Source: New York Times
Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period. Source: New York Times
Breakthrough Infections and the Delta Variant: What to Know
Scientific understanding of the coronavirus variant is changing quickly. Here’s a recap of the most important findings. Source: New York Times
Should People With Immune Problems Get Third Vaccine Doses?
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own. Source: New York Times
Three Studies, One Result: Vaccines Point the Way Out of the Pandemic
New scientific research underscores the effectiveness of vaccines and their versatility in the fight against the coronavirus. Source: New York Times
Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds
Immune cells are still organizing to fight the coronavirus months after inoculation, scientists reported. Source: New York Times
Scientists Report Earliest Known Coronavirus Cases in Five US States
Blood drawn from nine people in the earliest days of the pandemic tested positive for the infection. But some experts questioned the results. Source: New York Times
Vaccines Are Effective Against the New York Variant, Studies Find
The research adds to a growing number of findings suggesting the Pfizer and Moderna shots are protective against the variants identified so far. Source: New York Times
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
A clinical trial found no symptomatic infections among vaccinated children ages 12 to 15, the companies said, and there were no serious side effects. The data have not yet been reviewed by independent experts. Source: New York Times
A New Coronavirus Variant Is Spreading in New York, Researchers Report
The variant contains a mutation thought to help the virus dodge the immune system, scientists said. Source: New York Times
Immunity to the Coronavirus May Last Years, New Data Hint
Blood samples from recovered patients suggest a powerful, long-lasting immune response, researchers reported. Source: New York Times